Netherlands · Series A startup

Who invested in Anaheim Bio

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechPharma

Raised this month

Funding summaryUpdated 7 Nov 2026

$45Mraised across 1 round since 2026, from 5 sources

Latest round
Series A, $45MNov 2026
Investors
6
See who backed them

The rounds

  1. Nov 2026

Everyone who backed them

Novartis Venture FundCorporate VC1round
RTW Investments LLCGrowth equity1round
Thuja CapitalVC firm1round
Droia VenturesVC firm1round
RV InvestVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Anaheim Bio

Who invested in Anaheim Bio?

Anaheim Bio's investors include Novartis Venture Fund, RTW Investments LLC, Thuja Capital, Frazier Life Sciences and Droia Ventures, and 1 more on record.

How much has Anaheim Bio raised?

Anaheim Bio has raised $45M across 1 round since 2026.

When did Anaheim Bio last raise?

Anaheim Bio's most recent round was a Series A of $45M in Nov 2026.

What was Anaheim Bio's biggest round?

Its most recent round, $45M in Nov 2026, is also its largest on record.

Who backed Anaheim Bio first?

Anaheim Bio's first round on record, in Nov 2026, was backed by Novartis Venture Fund, RTW Investments LLC and Thuja Capital and 3 others.

What stage is Anaheim Bio at?

Anaheim Bio's latest named round is a Series A, in Nov 2026.

Where is Anaheim Bio based?

Anaheim Bio is based in the Netherlands.

Companies like Anaheim Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.